Skip to main content
. 2019 May 13;23(7):4770–4778. doi: 10.1111/jcmm.14365

Figure 6.

Figure 6

Combination of sorafenib with miR‐124/506 overexpression or enhancer of zeste homolog 2 inhibitor improves the survival in mice model. Survival curve of the mice were injected with TC‐07 or TC‐13 cells (1 × 106 cells/mouse) by subaxillary inoculation. The sorafenib was given every day for 20 d by 20 mg/kg with intravenous injection or a combination with miR‐124/506 mimics or the amount of EPZ‐6438 by 200 mg/kg. Each group has 20 mice